Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)

Evaluation: Based on all recent filings, financial statements, and news.

See full evaluation
Ask a question about Jiangsu Nhwa Pharmaceutical Co., Ltd. (002262)

Go deeper and ask any question about 002262

Company Performance

Current Price

as of Sep 13, 2024

$3.50

P/E Ratio

22.29

Market Cap

$3.56B

Description

Jiangsu Nhwa Pharmaceutical Co., Ltd. engages in the pharmaceutical production, research and development, and sales. It specializes in central nervous drugs and cardiovascular and cerebrovascular drugs. Its pharmaceutical manufacturing business covers production of central nervous products, including anesthetic, mental and neurological pharmaceutical raw materials and their preparations. The company was founded in 1978 and is headquartered in Xuzhou, China.

Metrics

Overview

  • HQXuzhou, JS
  • SectorHealth Technology
  • IndustryPharmaceuticals: Major
  • Ticker002262
  • Price$3.495666+0.18%

Trading Information

  • Market Cap$3.56B
  • Float53.54%
  • Average Daily Volume (1m)4,905,606
  • Average Daily Volume (3m)5,604,157
  • EPS$1.11

Company

  • Revenue$5.33B
  • Rev Growth (1yr)15.13%
  • Net Income$363.64M
  • Gross Margin71.60%
  • EBITDA Margin33.72%
  • EBITDA$467.88M
  • EV$20.59B
  • EV/Revenue3.86
  • P/E22.29
  • P/S4.69